|Day Low/High||3.04 / 3.09|
|52 Wk Low/High||1.79 / 3.98|
Shares of Novogen (NVGN) were down in late morning trading Monday after the Australian and U.S. biotechnology company announced it had conducted a private placement and offered rights to shareholders.
Shares of Novogen (NVGN) were up Friday after the company announced an MOU with the Feinstein Institute for Medical Research of New York to collaborate on brain cancer treatments.
Novagen (NVGN) shares rose double digits today after announcing promising results from its melanoma treatment study.
Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
These stocks look ready to break out and trade higher from current levels.
Itty bitty biotechs are big again, thanks to the H1N1 virus, cancer drug abstracts, and Vanda's recent success.
A reader writes in with a different view. Plus, Biovail, Gold Fields, Novatel and more.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.